Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PN-401 with 5-FU and Leucovorin in Advanced Gastric Cancer
NCT00004233Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2001
- Primary completion
- Jan 2007
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of uridine triacetate in gastric cancer (GC), esophageal cancer, sponsored by SWOG Cancer Research Network. Started Feb 2001; status: completed.
02
Drugs
uridine triacetate
03
Conditions
gastric cancer (GC)esophageal cancer
Beyond the preview
Go deeper on NCT00004233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004233.